A human factor VIII inhibitor tolerating the endogenous FVIII with a unique A2 domain substitution in CRM+ haemophilia A.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F03%3A00000054" target="_blank" >RIV/00023736:_____/03:00000054 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
A human factor VIII inhibitor tolerating the endogenous FVIII with a unique A2 domain substitution in CRM+ haemophilia A.
Original language description
A human factor VIII inhibitor tolerating the endogenous FVIII with a unique A2 domain substitution in CRM+ haemophilia A.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NM7615" target="_blank" >NM7615: Implementation of high-performance liquid chromatography (HPLC) to the molecular testing of inherited haemostatic defects and to the histocompatibility tests for haematopoietic stem cell transplantation (HSCT).</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2003
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Thrombosis and Haemostasis [online]
ISSN
1740-3332
e-ISSN
—
Volume of the periodical
1
Issue of the periodical within the volume
S1
Country of publishing house
US - UNITED STATES
Number of pages
1
Pages from-to
"P0468"-"P0468"
UT code for WoS article
—
EID of the result in the Scopus database
—